Abstract
We present a case of a patient that experienced severe hemorrhagic occlusive retinal vasculitis secondary to injection of 1.0 mg/0.1 ml of intracameral vancomycin for endophthalmitis prophylaxis after an uneventful cataract surgery. The case is especially unique in that our patient ended up maintaining 20/25 vision with an ocular disease that is typically visually threatening. This may be due to the aggressive administration of periocular and oral steroids combined with scheduled anti-VEGF injections that were later transitioned into a treat and extend regimen.
MeSH terms
-
Aged
-
Anti-Bacterial Agents / adverse effects*
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
-
Antiviral Agents / therapeutic use
-
Benzophenones / therapeutic use
-
Bromobenzenes / therapeutic use
-
Cataract Extraction
-
Drug Combinations
-
Endophthalmitis / microbiology
-
Endophthalmitis / prevention & control
-
Eye Infections, Bacterial / microbiology
-
Eye Infections, Bacterial / prevention & control
-
Female
-
Fluorescein Angiography
-
Glucocorticoids / therapeutic use
-
Humans
-
Prednisone / therapeutic use
-
Retinal Hemorrhage / chemically induced
-
Retinal Hemorrhage / diagnosis
-
Retinal Hemorrhage / drug therapy*
-
Retinal Vasculitis / chemically induced
-
Retinal Vasculitis / diagnosis
-
Retinal Vasculitis / drug therapy*
-
Tomography, Optical Coherence
-
Valacyclovir / therapeutic use
-
Vancomycin / adverse effects*
Substances
-
Anti-Bacterial Agents
-
Anti-Inflammatory Agents, Non-Steroidal
-
Antiviral Agents
-
Benzophenones
-
Bromobenzenes
-
Drug Combinations
-
Glucocorticoids
-
Vancomycin
-
bromfenac
-
Valacyclovir
-
Prednisone